Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for the effective treatment of pancreatic cancer-Reference-Cited by-同舟云学术

Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for the effective treatment of pancreatic cancer

Published:2014-02 Issue:2 Volume:10 Page:463-472
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Zeng Linjuan,Li Jingguo,Wang Yong,Qian Chenchen,Chen Yinting,Zhang Qiubo,Wu Wei,Lin Zhong,Liang Jianzhong,Shuai Xintao,Huang Kaihong

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference48 articles.

1. Pancreatic cancer;Li;Lancet,2004

2. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma;Morris;Nat Rev Cancer,2010

3. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses;Jones;Science,2008

4. A gene expression signature associated with “K-Ras addiction” reveals regulators of EMT and tumor cell survival;Singh;Cancer Cell,2009

5. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas;Smit;Nucleic Acids Res,1988

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors;Journal of Controlled Release;2024-09

2. Trace elements in pancreatic cancer;Cancer Medicine;2024-07

3. Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer;European Journal of Pharmaceutics and Biopharmaceutics;2023-11

4. Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer;Acta Biomaterialia;2023-09

5. Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis;Translational Research;2023-05